CA Stock MarketDetailed Quotes
CLAS.H Claritas Pharmaceuticals Inc
- 0.025
- 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
914.65KMarket Cap-151P/E (TTM)
0.000High0.000Low0Volume0.000Open0.025Pre Close0.00Turnover0.02552wk High0.00%Turnover Ratio36.59MShares0.02552wk Low-0.165EPS TTM809.78KFloat Cap0.025Historical High0.12P/E (Static)32.39MShs Float0.025Historical Low0.207EPS LYR0.00%Amplitude--Dividend TTM0.20P/B1Lot Size--Div YieldTTM
Claritas Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -37.47%514K | 49.18%549K | -71.35%159K | -101.95%-184K | -418.47%-1.71M | -62.24%822K | -88.28%368K | -84.58%555K | -14.87%9.45M | -83.65%536K |
| Selling and administrative expenses | -37.47%514K | 49.18%549K | -55.59%159K | -48.89%1.87M | -27.65%348K | -27.89%822K | -71.07%368K | -53.39%358K | 9.22%3.66M | -51.51%481K |
| -General and administrative expense | -37.47%514K | 49.18%549K | -55.59%159K | -48.89%1.87M | -27.65%348K | -27.89%822K | -71.07%368K | -53.39%358K | 9.22%3.66M | -51.51%481K |
| Research and development costs | ---- | ---- | --0 | -135.49%-2.06M | ---- | ---- | ---- | -93.04%197K | -25.29%5.79M | -97.59%55K |
| Operating profit | 37.47%-514K | -49.18%-549K | 71.35%-159K | 101.95%184K | 418.47%1.71M | 62.24%-822K | 88.28%-368K | 84.58%-555K | 14.87%-9.45M | 83.65%-536K |
| Net non-operating interest income (expenses) | -21.02%695K | -79.20%-715K | -100.90%-20K | -6.27%-271K | -248.40%-2.94M | 48.40%880K | -188.86%-399K | 586.78%2.21M | 4.85%-255K | -1,417.19%-843K |
| Non-operating interest income | -31.30%709K | --0 | -98.28%39K | ---- | ---- | 63.03%1.03M | --0 | --2.26M | ---- | ---- |
| Non-operating interest expense | -90.79%14K | 79.20%715K | 15.69%59K | 7.66%225K | 80.77%-20K | 280.00%152K | 102.54%399K | -88.77%51K | 36.60%209K | 41.90%-104K |
| Total other finance cost | ---- | ---- | ---- | 0.00%46K | ---- | ---- | ---- | ---- | -60.00%46K | ---- |
| Other net income (expenses) | -121.16%-2.6M | 96.36%-587K | 655.52%12.28M | -188.59%-16.13M | -213.27%-7.11M | |||||
| Gain on sale of security | ---- | ---- | ---- | 502.31%2.87M | ---- | ---- | ---- | ---- | -96.64%477K | ---- |
| Special income (charges) | ---- | ---- | -121.16%-2.6M | 79.16%-3.46M | ---- | ---- | ---- | 655.52%12.28M | -512.96%-16.61M | -264.26%-7.59M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | 100.45%55K | 29.83%-12.17M | ---- | ---- | ---- | -541.75%-12.34M | -166.26%-17.34M | -199.19%-3.07M |
| -Less:Impairment of capital assets | ---- | ---- | 4,068.85%2.54M | -53.71%15.63M | ---- | ---- | ---- | 110.46%61K | 1,254.55%33.77M | 235.81%10.48M |
| -Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --180K | ---- |
| Income before tax | 212.07%181K | -64.80%-1.26M | -119.93%-2.78M | 97.39%-674K | 78.60%-1.82M | 112.89%58K | 92.78%-767K | 322.45%13.93M | -477.91%-25.83M | -377.03%-8.49M |
| Income tax | 0 | 0 | -4,227.27%-476K | -5.67%-4.88M | -69,671.43%-4.88M | 0 | 0 | -108.40%-11K | -4,568.69%-4.62M | -100.37%-7K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 143.83%181K | 77.57%-1.94M | -116.50%-2.3M | 119.85%4.21M | 92.29%-654K | 57.68%-413K | -61.74%-8.67M | 318.06%13.94M | -405.87%-21.21M | -822.04%-8.48M |
| Net income continuous operations | 212.07%181K | -64.80%-1.26M | -116.50%-2.3M | 119.85%4.21M | 136.15%3.07M | 105.94%58K | 85.68%-767K | 318.06%13.94M | -405.87%-21.21M | -822.04%-8.48M |
| Net income discontinuous operations | --0 | 91.39%-680K | ---- | ---- | ---- | ---471K | ---7.9M | ---- | ---- | ---- |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 143.83%181K | 77.57%-1.94M | -116.50%-2.3M | 119.85%4.21M | 92.29%-654K | 57.68%-413K | -61.74%-8.67M | 318.06%13.94M | -405.87%-21.21M | -822.04%-8.48M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 143.83%181K | 77.57%-1.94M | -116.50%-2.3M | 119.85%4.21M | 92.29%-654K | 57.68%-413K | -61.74%-8.67M | 318.06%13.94M | -405.87%-21.21M | -822.04%-8.48M |
| Diluted earnings per share | 103.01%0.0051 | 98.06%-0.0582 | -113.93%-0.0836 | 116.00%0.16 | 95.00%-0.02 | -325.00%-0.17 | -1,400.00%-3 | 242.86%0.6 | -225.00%-1 | -300.00%-0.4 |
| Basic earnings per share | 103.01%0.0051 | 98.06%-0.0582 | -113.93%-0.0836 | 116.00%0.16 | 95.00%-0.02 | -325.00%-0.17 | -1,400.00%-3 | 242.86%0.6 | -600.00%-1 | -558.82%-0.4 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data